摩熵化学
数据库官网
小程序
打开微信扫一扫
首页 分子通 化学资讯 化学百科 反应查询 关于我们
请输入关键词

3-{(S)-2-[3-((S)-2-tert-Butoxycarbonylamino-4-isopropoxycarbonyl-butyrylamino)-benzoylamino]-4-isopropoxycarbonyl-butyrylamino}-benzoic acid benzyl ester | 233692-15-4

中文名称
——
中文别名
——
英文名称
3-{(S)-2-[3-((S)-2-tert-Butoxycarbonylamino-4-isopropoxycarbonyl-butyrylamino)-benzoylamino]-4-isopropoxycarbonyl-butyrylamino}-benzoic acid benzyl ester
英文别名
——
3-{(S)-2-[3-((S)-2-tert-Butoxycarbonylamino-4-isopropoxycarbonyl-butyrylamino)-benzoylamino]-4-isopropoxycarbonyl-butyrylamino}-benzoic acid benzyl ester化学式
CAS
233692-15-4
化学式
C42H52N4O11
mdl
——
分子量
788.895
InChiKey
VRMCLTCTTXIHRP-HEVIKAOCSA-N
BEILSTEIN
——
EINECS
——
  • 物化性质
  • 计算性质
  • ADMET
  • 安全信息
  • SDS
  • 制备方法与用途
  • 上下游信息
  • 反应信息
  • 文献信息
  • 表征谱图
  • 同类化合物
  • 相关功能分类
  • 相关结构分类

计算性质

  • 辛醇/水分配系数(LogP):
    6.08
  • 重原子数:
    57.0
  • 可旋转键数:
    18.0
  • 环数:
    3.0
  • sp3杂化的碳原子比例:
    0.4
  • 拓扑面积:
    204.53
  • 氢给体数:
    4.0
  • 氢受体数:
    11.0

反应信息

  • 作为反应物:
    描述:
    3-{(S)-2-[3-((S)-2-tert-Butoxycarbonylamino-4-isopropoxycarbonyl-butyrylamino)-benzoylamino]-4-isopropoxycarbonyl-butyrylamino}-benzoic acid benzyl ester 在 palladium on activated charcoal 氢气 、 O-(benzotriazol-1-yl)-N,N,N',N'-tetramethyluronium tetrafluoroborate 、 N,N-二异丙基乙胺三氟乙酸 作用下, 以 甲醇二氯甲烷N,N-二甲基甲酰胺 为溶剂, 25.0 ℃ 、101.33 kPa 条件下, 反应 5.5h, 生成 3-[(S)-2-(3-{(S)-2-[3-((S)-2-Amino-4-isopropoxycarbonyl-butyrylamino)-benzoylamino]-4-isopropoxycarbonyl-butyrylamino}-benzoylamino)-4-isopropoxycarbonyl-butyrylamino]-benzoic acid
    参考文献:
    名称:
    Large Increase in Cation Binding Affinity of Artificial Cyclopeptide Receptors by an Allosteric Effect
    摘要:
    The receptor properties of a cyclopeptide composed of L-glutamic acid and 3-aminobenzoic acid in an alternating sequence are described. H-1 NMR, NOESY Nh LR. and FT-IR spectroscopic investigations show that this cyclic peptide is relatively flexible in solution. Still, it is able to bind cations by cation-pi interactions. For the n-butyltrimethylammonium iodide complex, for example, an association constant of 300 M-1 has been determined in chloroform Besides cations, the cyclopeptide is also able to bind certain anions, such as sulfonates or phosphonates, at a second binding site. Nh IR and FT-IR spectroscopic investigations show that these anions are hydrogen bonded to the peptidic NH groups. Anion complexation results in an increase of the cyclic peptide's cation affinity by a factor of 10(3)-10(4). The cyclopeptide-tosylate complex structure in solution was assigned by FT-IR, H-1 NMR, and NOESY NMR spectroscopic methods as well as molecular modeling, This structure shows that the drastic increase in cation binding affinity can be correlated with a preorganization of the cyclic peptide by the anion as well as electrostatic interactions between anion and cationic substrates in the final complex. Therefore, the influence of the anions on the complexing behavior of the cyclopeptide can be regarded as an allosteric effect. Association constants of the K+-18-crown-6, Na+-15-crown-5, and n-butyltrimethylammonium cation complexes have been determined by dilution and competitive NMR titrations.
    DOI:
    10.1021/ja983970j
  • 作为产物:
    参考文献:
    名称:
    Large Increase in Cation Binding Affinity of Artificial Cyclopeptide Receptors by an Allosteric Effect
    摘要:
    The receptor properties of a cyclopeptide composed of L-glutamic acid and 3-aminobenzoic acid in an alternating sequence are described. H-1 NMR, NOESY Nh LR. and FT-IR spectroscopic investigations show that this cyclic peptide is relatively flexible in solution. Still, it is able to bind cations by cation-pi interactions. For the n-butyltrimethylammonium iodide complex, for example, an association constant of 300 M-1 has been determined in chloroform Besides cations, the cyclopeptide is also able to bind certain anions, such as sulfonates or phosphonates, at a second binding site. Nh IR and FT-IR spectroscopic investigations show that these anions are hydrogen bonded to the peptidic NH groups. Anion complexation results in an increase of the cyclic peptide's cation affinity by a factor of 10(3)-10(4). The cyclopeptide-tosylate complex structure in solution was assigned by FT-IR, H-1 NMR, and NOESY NMR spectroscopic methods as well as molecular modeling, This structure shows that the drastic increase in cation binding affinity can be correlated with a preorganization of the cyclic peptide by the anion as well as electrostatic interactions between anion and cationic substrates in the final complex. Therefore, the influence of the anions on the complexing behavior of the cyclopeptide can be regarded as an allosteric effect. Association constants of the K+-18-crown-6, Na+-15-crown-5, and n-butyltrimethylammonium cation complexes have been determined by dilution and competitive NMR titrations.
    DOI:
    10.1021/ja983970j
点击查看最新优质反应信息

文献信息

  • A New Cyclic Pseudopeptide Composed of (<scp>l</scp>)-Proline and 3-Aminobenzoic Acid Subunits as a Ditopic Receptor for the Simultaneous Complexation of Cations and Anions
    作者:Stefan Kubik、Richard Goddard
    DOI:10.1021/jo991087d
    日期:1999.12.1
    The synthesis and receptor properties of a cyclic pseudopeptide composed of (L)-proline and the nonnatural amino acid 3-aminobenzoic acid in an alternating sequence are described. The structure of cyclo[(L)Pro-AB](3) was determined in the solid state by X-ray crystallography and in solution by one- and two-dimensional NMR techniques and FT-IR spectroscopy. The cyclic peptide preferentially adopts conformations comparable with the cone conformation of calixarenes. Similar to calixarenes, cyclo[(L)Pro-AB](3) is able to bind cations by cation-pi interactions with its aromatic subunits. In some complexes, the peptide NH groups interact additionally with anions and the cyclic peptide thus behaves as a ditopic receptor. The structure of the ternary complex between cyclo[(L)Pro-AB](3) and N-methylquinuclidinium iodide was determined by X-ray crystallography. Spectroscopic investigations show that this complex has a similar geometry in solution. Stability constants of complexes of the cyclopeptide with various ion pairs have been determined. Crossover experiments show that electrostatic interactions between cation and anion complexed by cyclo[(L)Pro-AB](3) result in cooperative effects of either ion on the complexation of the corresponding counterion. The binding properties of cyclo[(L)Pro-AB](3) are correlated with its conformation in solution. The properties of related cyclic hexapeptides in which one or two (L)-proline subunits are replaced by (L)-glutamic acid are also described. In comparison with cyclo[(L)Pro-AB](3), these peptides possess a reduced cation and anion affinity. Anion complexation is weakened because the amide NH groups at the glutamic acid subunits are involved in strong intramolecular hydrogen bonds and are not available for interactions with other partners. Consequently, the cation complex stabilities also decrease. The amino acid subunits obviously influence the receptor properties of such cyclopeptides by controlling their solution conformation.
查看更多

同类化合物

(βS)-β-氨基-4-(4-羟基苯氧基)-3,5-二碘苯甲丙醇 (S,S)-邻甲苯基-DIPAMP (S)-(-)-7'-〔4(S)-(苄基)恶唑-2-基]-7-二(3,5-二-叔丁基苯基)膦基-2,2',3,3'-四氢-1,1-螺二氢茚 (S)-盐酸沙丁胺醇 (S)-3-(叔丁基)-4-(2,6-二甲氧基苯基)-2,3-二氢苯并[d][1,3]氧磷杂环戊二烯 (S)-2,2'-双[双(3,5-三氟甲基苯基)膦基]-4,4',6,6'-四甲氧基联苯 (S)-1-[3,5-双(三氟甲基)苯基]-3-[1-(二甲基氨基)-3-甲基丁烷-2-基]硫脲 (R)富马酸托特罗定 (R)-(-)-盐酸尼古地平 (R)-(-)-4,12-双(二苯基膦基)[2.2]对环芳烷(1,5环辛二烯)铑(I)四氟硼酸盐 (R)-(+)-7-双(3,5-二叔丁基苯基)膦基7''-[((6-甲基吡啶-2-基甲基)氨基]-2,2'',3,3''-四氢-1,1''-螺双茚满 (R)-(+)-7-双(3,5-二叔丁基苯基)膦基7''-[(4-叔丁基吡啶-2-基甲基)氨基]-2,2'',3,3''-四氢-1,1''-螺双茚满 (R)-(+)-7-双(3,5-二叔丁基苯基)膦基7''-[(3-甲基吡啶-2-基甲基)氨基]-2,2'',3,3''-四氢-1,1''-螺双茚满 (R)-(+)-4,7-双(3,5-二-叔丁基苯基)膦基-7“-[(吡啶-2-基甲基)氨基]-2,2”,3,3'-四氢1,1'-螺二茚满 (R)-3-(叔丁基)-4-(2,6-二苯氧基苯基)-2,3-二氢苯并[d][1,3]氧杂磷杂环戊烯 (R)-2-[((二苯基膦基)甲基]吡咯烷 (R)-1-[3,5-双(三氟甲基)苯基]-3-[1-(二甲基氨基)-3-甲基丁烷-2-基]硫脲 (N-(4-甲氧基苯基)-N-甲基-3-(1-哌啶基)丙-2-烯酰胺) (5-溴-2-羟基苯基)-4-氯苯甲酮 (5-溴-2-氯苯基)(4-羟基苯基)甲酮 (5-氧代-3-苯基-2,5-二氢-1,2,3,4-oxatriazol-3-鎓) (4S,5R)-4-甲基-5-苯基-1,2,3-氧代噻唑烷-2,2-二氧化物-3-羧酸叔丁酯 (4S,4''S)-2,2''-亚环戊基双[4,5-二氢-4-(苯甲基)恶唑] (4-溴苯基)-[2-氟-4-[6-[甲基(丙-2-烯基)氨基]己氧基]苯基]甲酮 (4-丁氧基苯甲基)三苯基溴化磷 (3aR,8aR)-(-)-4,4,8,8-四(3,5-二甲基苯基)四氢-2,2-二甲基-6-苯基-1,3-二氧戊环[4,5-e]二恶唑磷 (3aR,6aS)-5-氧代六氢环戊基[c]吡咯-2(1H)-羧酸酯 (2Z)-3-[[(4-氯苯基)氨基]-2-氰基丙烯酸乙酯 (2S,3S,5S)-5-(叔丁氧基甲酰氨基)-2-(N-5-噻唑基-甲氧羰基)氨基-1,6-二苯基-3-羟基己烷 (2S,2''S,3S,3''S)-3,3''-二叔丁基-4,4''-双(2,6-二甲氧基苯基)-2,2'',3,3''-四氢-2,2''-联苯并[d][1,3]氧杂磷杂戊环 (2S)-(-)-2-{[[[[3,5-双(氟代甲基)苯基]氨基]硫代甲基]氨基}-N-(二苯基甲基)-N,3,3-三甲基丁酰胺 (2S)-2-[[[[[((1S,2S)-2-氨基环己基]氨基]硫代甲基]氨基]-N-(二苯甲基)-N,3,3-三甲基丁酰胺 (2S)-2-[[[[[[((1R,2R)-2-氨基环己基]氨基]硫代甲基]氨基]-N-(二苯甲基)-N,3,3-三甲基丁酰胺 (2-硝基苯基)磷酸三酰胺 (2,6-二氯苯基)乙酰氯 (2,3-二甲氧基-5-甲基苯基)硼酸 (1S,2S,3S,5S)-5-叠氮基-3-(苯基甲氧基)-2-[(苯基甲氧基)甲基]环戊醇 (1S,2S,3R,5R)-2-(苄氧基)甲基-6-氧杂双环[3.1.0]己-3-醇 (1-(4-氟苯基)环丙基)甲胺盐酸盐 (1-(3-溴苯基)环丁基)甲胺盐酸盐 (1-(2-氯苯基)环丁基)甲胺盐酸盐 (1-(2-氟苯基)环丙基)甲胺盐酸盐 (1-(2,6-二氟苯基)环丙基)甲胺盐酸盐 (-)-去甲基西布曲明 龙蒿油 龙胆酸钠 龙胆酸叔丁酯 龙胆酸 龙胆紫-d6 龙胆紫